VetFluid

Antibiotic Therapy

Amoxicillin/Clavulanate

Beta-lactamase-inhibitor-potentiated aminopenicillin · bactericidal (cell-wall synthesis inhibitor)

Species: Dogs & Cats11 dose protocols9 dosage forms

This page is a calculation and educational reference for veterinarians and veterinary students. It does not replace examination, culture and susceptibility testing, clinical judgment, or the attending veterinarian's final decision.

Drug overview

Beta-lactamase-inhibitor-potentiated aminopenicillin · bactericidal (cell-wall synthesis inhibitor)

General dose: 12.5 mg/kg PO · every 12 hSource: Plumb's

Spectrum of activity

A broad-spectrum, bactericidal aminopenicillin; adding clavulanic acid (a beta-lactamase inhibitor) makes it active against beta-lactamase-positive staphylococci and anaerobes (including Bacteroides). Its spectrum covers Gram-positives (staphylococci, streptococci, enterococci, Listeria, Actinomyces), many Gram-negatives (Pasteurella, E. coli, Proteus, Haemophilus) and spirochetes (Borrelia of Lyme disease, Leptospira). But it has no activity against Pseudomonas, Enterobacter, Serratia and methicillin-resistant staph (MRSA/MRSP); and because its mechanism is cell-wall inhibition, it has no effect on cell-wall-free (Mycoplasma) or intracellular (Rickettsia, Ehrlichia, Chlamydia) bacteria.
Amoxicillin/Clavulanate spectrum of activity chart
Open the full-size spectrum image

Veterinary uses and doses

General (susceptible) infection

DogSource: Plumb's

13.75 mg/kg · every 12 h

CatSource: Plumb's

Cat: 12.5 mg/kg · every 12 h

Urinary tract infection (UTI)

DogSource: ISCAID 2019

12.5 mg/kg · every 12 h · 3–5 days

Clinical note: For sporadic cystitis, plain amoxicillin is first-line (ISCAID 2019); reserve co-amoxiclav for recurrent/complicated infection or beta-lactamase-producing bacteria.
CatSource: ISCAID 2019

Cat: 10–20 mg/kg · every 12 h · 3–5 days

Clinical note: For sporadic cystitis, plain amoxicillin is first-line and co-amoxiclav is reserved for recurrent/complicated or beta-lactamase-positive cases (ISCAID 2019). In cats most lower-urinary signs are idiopathic (FIC) and non-infectious — confirm infection by culture before giving an antibiotic.

Skin & soft tissue

DogSource: Plumb's

Soft tissue/skin: 12.5 mg/kg · every 12 h · 5–7 days

DogSource: Plumb's

Deep pyoderma: 12.5 mg/kg · every 12 h · 14–120 days

DogSource: Aucoin 2002

Non-superficial pyoderma: 10–25 mg/kg · every 12 h · 3–6 weeks

Clinical note: Maximum 650 mg per dose. If no response by the end of the first week, increase to three times daily; and if there is still no response by the end of the second week, stop treatment.
DogSource: Hillier 2006

Recurrent pyoderma: 13.75–22 mg/kg · every 8–12 h

CatSource: Greene 2006

Cat: 10–20 mg/kg · every 12 h · 5–7 days

Sepsis / bacteremia

DogSource: Plumb's

Bacteremia (oral step-down): 22 mg/kg · every 8–12 h · 7 days

Clinical note: ⚠️ Active sepsis/bacteremia requires initial intravenous therapy. Oral co-amoxiclav is not adequate for a septic patient; this dose is only for oral step-down after the patient is stabilized.
CatSource: Greene 2006

Cat — bacteremia/pneumonia (oral step-down): 10–20 mg/kg · every 8 h · 7–10 days

Clinical note: ⚠️ Active sepsis/bacteremia requires initial intravenous therapy. Oral co-amoxiclav is not adequate for a septic patient; this dose is only for oral step-down after the patient is stabilized.

Dosage forms

Safety and clinical notes

Cited sources

  1. Plumb's
  2. ISCAID 2019
  3. Aucoin 2002
  4. Hillier 2006
  5. Greene 2006
Calculate a weight-based dose

Drug-data last updated: